Skip to main content

Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020).

Publication ,  Journal Article
Warshaw, EM; Peterson, MY; DeKoven, JG; Adler, BL; Pratt, MD; Belsito, DV; Atwater, AR; Houle, M-C; Dunnick, CA; Yu, J; Taylor, JS; Reeder, MJ ...
Published in: Dermatitis
August 22, 2024

Background: Mentha piperita (MP; peppermint) oil has many commercial uses. Objective: To characterize the epidemiology of contact allergy to MP oil 2% petrolatum. Methods: Retrospective analysis of North American Contact Dermatitis Group data (2009-2020). Results: Of 28,128 patients tested to MP, 161 (0.6%) had an allergic reaction. Most allergic patients were female (77.0%) and/or over 40 years of age (71.4%). The most common anatomical sites of dermatitis included face (31.7%; of these, one-third specified lips), hands (17.4%), and scattered/generalized (18.6%). Nearly one-third (30.4%) of reactions were strong (++)/extreme (+++), and 80.1% were considered currently relevant. Common sources included oral hygiene preparations, foods, and lip products. Co-reaction with at least 1 of the other 19 fragrance/plant-related screening test preparations occurred in 82.6% (133/161) of MP-allergic patients, most commonly Cananga odorata oil (42.9%), fragrance mix I (41.0%), hydroperoxides of linalool (35.7%), Compositae mix (35.4%), Jasminum officinale oil (31.9%), Myroxylon pereirae (31.7%), and propolis (28.1%). Co-reaction with at least 1 of the 3 most commonly used fragrance screening allergens (fragrance mix I, fragrance mix II, and/or Myroxylon pereirae) was 59.6%. Conclusions: Twelve-year prevalence of MP allergy was 0.6%. Approximately 40% of cases would have been missed if only fragrance screening allergens were tested.

Duke Scholars

Published In

Dermatitis

DOI

EISSN

2162-5220

Publication Date

August 22, 2024

Location

United States

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Warshaw, E. M., Peterson, M. Y., DeKoven, J. G., Adler, B. L., Pratt, M. D., Belsito, D. V., … Botto, N. C. (2024). Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020). Dermatitis. https://doi.org/10.1089/derm.2024.0118
Warshaw, Erin M., Malina Yamashita Peterson, Joel G. DeKoven, Brandon L. Adler, Melanie D. Pratt, Donald V. Belsito, Amber R. Atwater, et al. “Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020).Dermatitis, August 22, 2024. https://doi.org/10.1089/derm.2024.0118.
Warshaw EM, Peterson MY, DeKoven JG, Adler BL, Pratt MD, Belsito DV, et al. Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020). Dermatitis. 2024 Aug 22;
Warshaw, Erin M., et al. “Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020).Dermatitis, Aug. 2024. Pubmed, doi:10.1089/derm.2024.0118.
Warshaw EM, Peterson MY, DeKoven JG, Adler BL, Pratt MD, Belsito DV, Atwater AR, Houle M-C, Dunnick CA, Yu J, Taylor JS, Silverberg JI, Reeder MJ, DeLeo VA, Mowad C, Botto NC. Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020). Dermatitis. 2024 Aug 22;

Published In

Dermatitis

DOI

EISSN

2162-5220

Publication Date

August 22, 2024

Location

United States

Related Subject Headings

  • Dermatology & Venereal Diseases
  • 3204 Immunology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences